Cargando…
Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
OBJECTIVE: To investigate the relationship between Hamilton Depression Rating Scale (HAM-D) score and psychiatrists’ judgment of working ability in patients with major depressive disorder (MDD) and painful physical symptoms. METHODS: This was a prospective, observational, 12-week study in patients w...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455004/ https://www.ncbi.nlm.nih.gov/pubmed/31040680 http://dx.doi.org/10.2147/NDT.S195445 |
_version_ | 1783409641931145216 |
---|---|
author | Kuga, Atsushi Otsubo, Tempei Tsuji, Toshinaga Hayashi, Shinji Imagawa, Hideyuki Fujikoshi, Shinji Escobar, Rodrigo |
author_facet | Kuga, Atsushi Otsubo, Tempei Tsuji, Toshinaga Hayashi, Shinji Imagawa, Hideyuki Fujikoshi, Shinji Escobar, Rodrigo |
author_sort | Kuga, Atsushi |
collection | PubMed |
description | OBJECTIVE: To investigate the relationship between Hamilton Depression Rating Scale (HAM-D) score and psychiatrists’ judgment of working ability in patients with major depressive disorder (MDD) and painful physical symptoms. METHODS: This was a prospective, observational, 12-week study in patients who received duloxetine or a selective serotonin reuptake inhibitor. Patients were ≥20 years old, resided in Japan, and had at least moderate depression (Quick Inventory of Depressive Symptomatology ≥16) and at least moderate painful physical symptoms (Brief Pain Inventory-Short Form average pain ≥3). The main outcome in this post-hoc analysis was the HAM-D17 cutoff best corresponding with patients’ working ability according to the investigator’s judgment. Area under the receiver-operator curve was used to determine the time point with the strongest relationship between HAM-D17 and working ability. The optimal HAM-D17 cutoff was determined based on the maximum of sensitivity (true positive rate) minus ([1 minus specificity] [true negative rate]). For the evaluation of binary data, a mixed effects model with repeated measures analysis was used. RESULTS: For the estimation of the HAM-D17 cutoff, the area under the receiver-operator curve was maximal at 12 weeks, when a HAM-D17 score of 6 resulted in the best correspondence with working ability in the combined study population. At 12 weeks, a HAM-D17 score of 6 also resulted in the maximum predictive ability in each of the two treatment groups separately. For predicted working ability at 12 weeks, 52.7% of duloxetine-treated patients achieved the HAM-D17 cutoff of ≤6, whereas 48.5% of SSRIs-treated patients achieved HAM-D17 ≤6 (P=0.477). CONCLUSION: In this study of patients with major depressive disorder and painful physical symptoms, a HAM-D17 score ≤6 corresponded best with patients’ working ability. This finding is consistent with previous studies showing that a HAM-D17 cutoff of ≤7 may overestimate functional recovery from MDD. |
format | Online Article Text |
id | pubmed-6455004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-64550042019-04-30 Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy Kuga, Atsushi Otsubo, Tempei Tsuji, Toshinaga Hayashi, Shinji Imagawa, Hideyuki Fujikoshi, Shinji Escobar, Rodrigo Neuropsychiatr Dis Treat Original Research OBJECTIVE: To investigate the relationship between Hamilton Depression Rating Scale (HAM-D) score and psychiatrists’ judgment of working ability in patients with major depressive disorder (MDD) and painful physical symptoms. METHODS: This was a prospective, observational, 12-week study in patients who received duloxetine or a selective serotonin reuptake inhibitor. Patients were ≥20 years old, resided in Japan, and had at least moderate depression (Quick Inventory of Depressive Symptomatology ≥16) and at least moderate painful physical symptoms (Brief Pain Inventory-Short Form average pain ≥3). The main outcome in this post-hoc analysis was the HAM-D17 cutoff best corresponding with patients’ working ability according to the investigator’s judgment. Area under the receiver-operator curve was used to determine the time point with the strongest relationship between HAM-D17 and working ability. The optimal HAM-D17 cutoff was determined based on the maximum of sensitivity (true positive rate) minus ([1 minus specificity] [true negative rate]). For the evaluation of binary data, a mixed effects model with repeated measures analysis was used. RESULTS: For the estimation of the HAM-D17 cutoff, the area under the receiver-operator curve was maximal at 12 weeks, when a HAM-D17 score of 6 resulted in the best correspondence with working ability in the combined study population. At 12 weeks, a HAM-D17 score of 6 also resulted in the maximum predictive ability in each of the two treatment groups separately. For predicted working ability at 12 weeks, 52.7% of duloxetine-treated patients achieved the HAM-D17 cutoff of ≤6, whereas 48.5% of SSRIs-treated patients achieved HAM-D17 ≤6 (P=0.477). CONCLUSION: In this study of patients with major depressive disorder and painful physical symptoms, a HAM-D17 score ≤6 corresponded best with patients’ working ability. This finding is consistent with previous studies showing that a HAM-D17 cutoff of ≤7 may overestimate functional recovery from MDD. Dove Medical Press 2019-04-05 /pmc/articles/PMC6455004/ /pubmed/31040680 http://dx.doi.org/10.2147/NDT.S195445 Text en © 2019 Kuga et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed |
spellingShingle | Original Research Kuga, Atsushi Otsubo, Tempei Tsuji, Toshinaga Hayashi, Shinji Imagawa, Hideyuki Fujikoshi, Shinji Escobar, Rodrigo Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy |
title | Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy |
title_full | Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy |
title_fullStr | Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy |
title_full_unstemmed | Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy |
title_short | Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy |
title_sort | analysis of ham-d scores and working ability in an observational study of japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or ssri monotherapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455004/ https://www.ncbi.nlm.nih.gov/pubmed/31040680 http://dx.doi.org/10.2147/NDT.S195445 |
work_keys_str_mv | AT kugaatsushi analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy AT otsubotempei analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy AT tsujitoshinaga analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy AT hayashishinji analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy AT imagawahideyuki analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy AT fujikoshishinji analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy AT escobarrodrigo analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy |